Detalles de la búsqueda
1.
Drug interactions between tyrosine kinase inhibitors (gefitinib and erlotinib) and warfarin: Assessment of international normalized ratio elevation characteristics and in vitro CYP2C9 activity.
J Oncol Pharm Pract
; 25(7): 1599-1607, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30253730
2.
[Effects of Seven Tyrosine Kinase Inhibitors on the Anticoagulation Activity of Warfarin].
Gan To Kagaku Ryoho
; 46(11): 1733-1739, 2019 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-31748483
3.
[Effects of Tyrosine Kinase Inhibitors on Control of PT-INR in Patients Receiving Warfarin].
Gan To Kagaku Ryoho
; 46(9): 1413-1419, 2019 Sep.
Artículo
en Japonés
| MEDLINE | ID: mdl-31530781
4.
Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers.
Cancer Chemother Pharmacol
; 87(6): 767-777, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33635392
5.
Identification of risk factors for venous thromboembolism and evaluation of Khorana venous thromboembolism risk assessment in Japanese lung cancer patients.
J Cardiol
; 75(1): 110-114, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31416782
Resultados
1 -
5
de 5
1
Próxima >
>>